
WHO stops short of advising proof of COVID shots for travel
The World Health Organization's Emergency Committee on Friday refrained from advising proof of COVID-19 vaccination or immunity as a condition for international travel, citing "critical unknowns" regarding their efficacy in reducing transmission and limited availability.
The 19-member panel of independent experts held their sixth meeting in a year under the chairmanship of French expert Didier Houssin, as the death toll from the pandemic neared two million.
The experts issued a series of recommendations, which WHO Director-General Tedros Adhanom Ghebreyesus accepted and sent to the U.N. agency's 194 member states, a statement said.
"At the present time, do not introduce requirements of proof of vaccination or immunity for international travel as a condition of entry as there are still critical unknowns regarding the efficacy of vaccination in reducing transmission and limited availability of vaccines," the WHO panel said.
"Proof of vaccination should not exempt international travellers from complying with other travel risk reduction measures," it added.
The panel urged countries to monitor virus variants such as those identified by Britain and South Africa to assess the effects on the efficacy of vaccines, drugs and diagnostic tests.
It called for promoting technology transfer to low- and middle-income countries with the potential capacity to accelerate global production of COVID-19 vaccines.
Further research was also needed on "critical unknowns about COVID-19 vaccination efficacy on transmission, duration of protection against severe disease and asymptomatic infection" as well as the duration of immunity following infection or vaccination, and protection after a single dose, the panel said. (Reporting by Emma Farge and Stephanie Nebehay; Editing by Michael Shields)

Latin America’s Covid vaccine scandal claims third health minister

Brasilia goes into lockdown as Brazil reels from Covid-19 surge

Blinken pledges cooperation in ‘virtual trips’ to Mexico, Canada

UN calls for immediate release of 317 girls abducted from school in Nigeria

Boeing CEO asked to testify in Ethiopian 737 MAX crash litigation

Iran 'can't act with impunity,' Biden says after US air strike

United States welcomes Indo-Pak ceasefire pact

US implicates Saudi crown prince in journalist Jamal Khashoggi's killing

Myanmar's UN envoy dramatically opposes coup in his country

EU medicines regulator approves Regeneron Covid-19 therapy

FDA advisory panel to review J&J Covid-19 vaccine with thumbs up expected

Bank of America gives paid time off for US staff to get Covid-19 vaccines

Biden administration to promote vaccination with businesses

Biden team looking to stop Saudi arms deals that help it attack others

Third US vaccine could raise question: Which Covid-19 shots are best?
- If cleared for emergency use, the J&J vaccine would offer a one-dose option that could help speed vaccinations.